Biopharma organizations are under increasing pressure to effectively leverage an expanding set of research, clinical, operational and real world data (RWD) to accelerate their trials and improve their chances of successfully launching new drugs. While data and advanced analytics hold great potential, accessing fit-for-purpose data sources, standardizing and integrating datasets, deriving actionable insights, scalability, and change management are major challenges along the way.

Download to find out more.